Cargando…
A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non–Small Cell Lung Cancer
PURPOSE: The aim of this study is to evaluate the safety and efficacy of ex vivo activated and expanded natural killer (NK) cell therapy (SNK01) plus pembrolizumab in a randomized phase I/IIa clinical trial. MATERIALS AND METHODS: Overall, 18 patients with advanced non–small cell lung cancer (NSCLC)...
Autores principales: | Kim, Eo Jin, Cho, Yong-Hee, Kim, Dong Ha, Ko, Dae-Hyun, Do, Eun-Ju, Kim, Sang-Yeob, Kim, Yong Man, Jung, Jae Seob, Kang, Yoonmi, Ji, Wonjun, Choi, Myeong Geun, Lee, Jae Cheol, Rho, Jin Kyung, Choi, Chang-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582480/ https://www.ncbi.nlm.nih.gov/pubmed/34856706 http://dx.doi.org/10.4143/crt.2021.986 |
Ejemplares similares
-
Two‐year efficacy of SNK01 plus pembrolizumab for non‐small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trial
por: Park, Hyung Jun, et al.
Publicado: (2022) -
Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non‐small cell lung cancer
por: Choi, Myeong Geun, et al.
Publicado: (2020) -
Validation of the General and Sport Nutrition Knowledge Questionnaire (GeSNK) in Spanish Adolescents
por: Manzano-Felipe, María Ángeles, et al.
Publicado: (2022) -
A Case of Phacomatosis Pigmentovascularis Type IIa in a Korean Infant
por: Ha, Jae Won, et al.
Publicado: (2017) -
Validation of a General and Sport Nutrition Knowledge Questionnaire in Adolescents and Young Adults: GeSNK
por: Calella, Patrizia, et al.
Publicado: (2017)